InvestorsHub Logo
Followers 81
Posts 24737
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 04/18/2024 9:18:46 AM

Thursday, April 18, 2024 9:18:46 AM

Post# of 27667
CTXR - .935/.95 Up from .8162

Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.